Cite

HARVARD Citation

    Jiang, L. et al. (2015). Survival Benefit of Neoadjuvant Chemotherapy for Resectable Cancer of the Gastric and Gastroesophageal Junction. Journal of clinical gastroenterology. 49 (5), p. . [Online]. 
  
Back to record